SXSW 2023

IP & The Rights of Plant Medicine


Patents, a traditional financial engine for biotech, are harder to win for plants that have been around for centuries, or molecules that have already made the rounds as street drugs. The next legal battlefront of drug development is the patents on psychedelics - will the rush to protect formulations simply to block competition hinder patenting an innovation that’s useful to patients? Will patents affect the barriers to entry for scientific research? The cost of accessing these therapies?

Other Resources / Information


  1. Ethics: who should profit & what should they control Possibility of issuing bad patents - the rush to block competition vs. patenting innovation
  2. Creating a niche patent that benefits the industry - filing patents that are chemically new vs. formulations of existing drugs and natural products
  3. Synthetic vs. natural psychedelics - developing drugs with efficacy and precision in mind



Sirita Wright, Senior Account Executive, KCSA Strategic Communications

Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Psychedelics
  • Track 2
  • Level: Advanced

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.